Details:
Through this partnership, Remedium aims to characterize the functionality of its lead candidate RMD 1101, in a range of in vitro, ex vivo, and in vivo efficacy models that will help to advance it toward IND.
Lead Product(s): RMD 1101
Therapeutic Area: Musculoskeletal Product Name: RMD 1101
Highest Development Status: Preclinical Product Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Tufts University
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement September 15, 2021